Previously, we found that human histocytic lymphoma U937 cells possessed high susceptibility to oridonininduced cell death, but the molecular mechanisms in response to oridonin remain unclear. In this study, U937 cells showed susceptible to apoptosis induced by 27 m mM oridonin and an agonistic anti-Fas IgM mAb (CH-11) (500 ng/ml) as a 
Apoptosis is a mechanism of cell death and is an important process for normal development and suppression of oncogensis. It is believed that apoptosis is largely initiated either from mitochondria (the intrinsic pathway) or through cell death receptors (the extrinsic pathway), followed by recruitment of cascade responses of caspases, a group of aspartate-specific cysteine proteases, 1) ultimately resulting in apoptosis. Among cell surface receptors, Fas receptor (CD95), a number of tumor necrosis factor (TNF) receptor family, exerts a critical role in triggering the apoptotic signaling and effector machinery.
2) Upon simulation of Fas with an agonistic anti-Fas IgM mAb or its natural ligand, FasL, several proteins with distinct functions, such as a cytosolic adaptor protein, FADD, 3) are recruited to the cytoplasmic domain of the Fas and in turn bind to the initiator caspase, caspase 8. Subsequently, the cleaved and activated caspase 8 causes a strictly regulated process involving activation of downstream effector caspases including caspase 3, 6 and 7, eventually leading to apoptosis. 4, 5) However, stimulation of Fas also results in activation of multiple kinases such as phosphatidylinositol 3-kinase (PI-3K) and mitogen-activated protein kinase (MAPK) other than those of effector caspases, 6, 7) indicating that phosphorylation-mediated signaling is likely to be involved in some aspects of Fas activation and regulation. In addition, MAPK proteins seem to be responsible for mitochondrial pathwaymediated apoptosis. 8) In some cases, the intrinsic pathway is thought to be a signal amplifer of the extrinsic pathway, due to the presence of intermediators such as Bid and phosphorylation-mediated kinases. 8, 9) Oridonin (Fig. 1) , a major component isolated from the ariel of Rabdosia rubscens, which has been used for treatment of pharyngitis, has anti-bacterial, anti-mutagenesis, scavenging active oxygen free radicals and anti-tumor effects. 10, 11) In the process of investigating the cytotoxic effects of oridonin on tumor cell lines, we found that human histocytic lymphoma U937 cells possessed much susceptibility to apoptosis induced by oridonin relative to other solid tumor cells such as human cervical cancer HeLa, and murine fibrosarcoma L929.
12) Therefore, the focus of our current study is to investigate the distinct mechanism of oridonin-indued U937 cell death and find out the novel pathway responsible for the high sensitivity of U937 to oridonin-induced apoptois.
In this study, we for the first time demonstrated that oridonin induced cell death through Fas/FasL signaling, that is, up-regualtion of Fas, FasL, and FADD expression; activation of caspase 8. Importantly, ERK functioned upstream of caspase 8, at the same time, regulated cytochrome c release from mitochondria, indicating induction of cytochrome c release amplified Fas/FasL signaling in response to oridonin through ERK as an intermediator. 
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MATERIALS AND METHODS
Chemical Material
Oridonin was obtained from the Kunming Institute of Botany, The Chinese Academy of Sciences (Kunming, China). The purity of oridonin was measured by HPLC and determined to be about 99%. Oridonin was dissolved in dimethyl sulfoxide (DMSO) to make a stock solution. DMSO concentration was kept below 0.1% in all the cell cultures and did not exert any detectable effect on cell growth or cell death.
Biological Materials Agonistic anti-Fas IgM mAb (clone CH-11) and anti-Fas IgG (clone UB2) were purchased from Medical & Biological Laborotories (Nagoya, Japan). Caspase 1 inhibitor, Ac-Val-Ala-Asp-CMK (Ac-YVAD-CMK) was from Bachem (Bubendorf, Switzerland); caspase 8 inhibitor, z-Ile-Glu-Thr-Asp-FMK (z-IETD-FMK) and caspase 10 inhibitor, z-Ala-Glu-Val-Asp-FMK (z-AEVD-FMK) were from Enzyme Systems (Livermore, CA, U.S.A.). Genistein, RNase A, proteinase K, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and propidium iodode (PI) were purchased from Sigma Chemical (St. Louis, MO, U.S.A.). ERK inhibitor PD98059, p38 MAPK inhibitor SB203580, and JNK inhibitor SP600125 were from Calbiochem (La Jolla, CA, U.S.A.). MEK inhibitor U0126 was purchased from Promega (Madison, WI, U.S.A.). Rabbit polyclone antibody against cytochrome c was purchased from Medical & Biological Laboratories (Osaka). Rabbit polyclone antibodies against ERK, caspase 8, FasL, and caspase 3 and mouse monoclone antibodies against phospho-ERK, Bcl-X L , Bcl-2, and Bax were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, U.S.A.).
Culture of U937 Cells Human histocytic lymphoma U937 (#CRL-1593.2) cells were obtained from American Type Culture Collection, (Manasas, VA, U.S.A.). The cells were cultured in RPMI 1640 (Gibco, Grand Island, NY, U.S.A.) supplemented with 10% FCS, 0.03% L-glutamine (Gibco), penicillin (100 U/ml) and streptomycin (100 mg/ml), and maintained at 37°C with 5% CO 2 in a humidified atmosphere.
Growth Inhibitory Test U937 cells (2ϫ10 5 /well) were seeded into 96-well culture plates (Nunc, Roskilde, Denmark). After overnight incubation with 10% FCS, various concentrations of oridonin, CH11 or UB2 were added to the plates. Following incubation, cell growth was measured at different time points by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as previously described with a plate reader (Bio-Rad, Hercules, CA, U.S.A.).
12) The percentage of inhibition was calculated as follows:
Observation of Morphologic Changes U937 cells in RPMI-1640 medium containing 10% FCS were seeded into 96-well culture plates. After overnight culture, oridonin was added to the cell culture and the cellular morphology was observed using phase-contrast microscopy (Olympus, Tokyo).
Flowcytometric Analysis U937 cells were harvested and washed with PBS. The cell pellets was fixed in 75% ethanol at 4°C overninght. After washing twice with PBS, the cells were stained with 1.0 ml of propidium iodode (PI) solution containing PI 50 mg/l, RNase A 1 g/l and 0.1% Triton X-100 in sodium citrate 3.8 mmol/l, followed by incuba- -free phosphate buffered-saline (PBS). The cell pellet was suspended in 100 ml cell lysis buffer (Tris-HCl 10 mmol/l pH 7.4, EDTA 10 mmol/l pH 8.0, Triton X-100 0.5%) and kept at 4°C for 30 min. The lysate was centrifuged at 7200ϫg for 20 min. The supernatants were incubated with 20 mg/ml RNase A (Sigma) at 37°C for 60 min, then incubated with 20 mg/ml proteinase K (Merck, Rahway, NJ, U.S.A.) at 37°C for 60 min. The supernatants were again mixed with NaCl 0.5 mol/l and 50% isopropyl alcohol overnight at Ϫ20°C, followed by centrifugation at 7200ϫg for 15 min. After drying, DNA sample was dissolved in TE buffer pH 7.8 (TrisHCl 10 mmol/l pH 7.4 and EDTA 1 mmol/l pH 8.0) and separated by 2% agarose gel electrophoresis at 100 V for 40 min and stained with 0.1 mg/l ethidium bromide.
PKC Activity Assay PKC activity assay was carried out according to the instructions of PepTag ® Non-Radioactive Protein Kinase C Assay Kit (Promega, WI, U.S.A.). Briefly, the cells (1ϫ10 6 cells) were washed once with PBS and lysed in lysis buffer, containing 20 mM Tris-HCl, 0.5 mM EGTA, 2 mM EDTA, 2 mM dithiothreitol, 1 mM phenylmethanesulfonyl fluoride (PMSF), and 10 mg/l leupeptin (pH 7.5). Assays were performed at 30°C in a total volume of 25 ml containing 5 ml PKC reaction 5ϫbuffer, 5 ml PLSRTLSVAAK peptide, 5 ml PKC activator, 1 ml peptide protection solution and 9 ml sample. Reactions were initiated by the addition of 9 ml sample and terminated after 30 min by incubation of the reaction mixture at 95°C for 10 min. After adding 1 ml of 80% glycerol, each sample was separated by 0.8% agarose gel electrophoresis at 100 V for 15 min.
Western Blot Analysis Western blot analysis was performed as previously described. 13) Briefly, both adherent and non-adherent cells were harvested; washed twice with PBS; and then lysed in lysis buffer (50 mM Hepes pH 7.4, 1% Triton X-100, 2 mM sodium orthovanadate, 100 mM sodium fluoride, 1 mM EDTA, 1 mM EGTA, 1 mM PMSF, 10 mg/ml aprotinin and 10 mg/ml leupeptin) at 4°C for 60 min. The lysate was centrifuged at 15000ϫg for 10 min and the supernatants were used for Western blotting analysis. Protein concentration was determined by the Folin assay. Equal amounts of total protein were separated by 12% gel electrophoresis and electrophoretially transferred to nitrocellulose membranes. Proteins were detected with the primary antibodies against Fas, FasL, FADD, caspase 8, ERK, phosphor-ERK (Santa Cruz Biotechnology, Santa Cruz, CA, U.S.A.) followed by horseradish perosidase (HRP)-conjugated secondary antibody (Santa Cruz Biotechnology) and visualized by using 3,3-diaminobenzidine tetrahydrochloride as the HRP substrate.
Statistical Analysis All data represent at least three independent experiments and are expressed as meanϮS.D., unless otherwise indicated. Statistical comparisons were made using Student's t-test. p-Values of less than 0.05 were considered to represent a statistically significant difference.
RESULTS
Differential Sensitivity of U937 Cells to Apoptosis
Induced by Oridonin, Agonistic Anti-Fas IgM mAb CH-11, and Anti-Fas IgG mAb UB2 To examine whether U937 cells were sensitive to Fas pathway-mediated apoptosis, agonistic anti-Fas IgM mAb CH-11 and anti-Fas IgG mAb UB2 were applied on the cells. As shown in Fig. 2A , treatment with CH11 200-500 ng/ml showed 25-30% reduction in U937 cell growth, relative to UB2 treatment group. More significant results were obtained when the cells were incubated with 27 mM ordonin for 12 h, which was consistent with our previous study. 14) Flowcytometric analysis further confirmed that CH11 and oridonin, but not UB2, had the ability to induce U937 cell apoptosis due to observation of sub-G1 peaks (Fig. 2B) . These results suggest that U937 cells might express Fas in certain degree, resulting in the sensitivation to agonistic anti-Fas IgM mAb CH-11.
Oridonin-Induced Apoptosis in U937 Cells Is Caspase 8 Dependent, but Caspase 1 and Caspase 10 Independent The death receptor pathway-mediated apoptosis is known to assemble receptor complexes that recruit initiator caspases such as caspase1, 2, 8 and/or 10. 15, 16) These activated initiator caspases then activate other downstream effector caspases, leading to apoptosis. In our previous study, oridonin-induced apoptosis was insensitive to inhibitors of caspase 8 and caspase 1 in several cell types such as L929 cells.
11) To determine whether theses initiator caspases are involved in oridonin-induced U937 cell apoptosis, relevant caspase inhibitors, caspase 1 inhibitor Ac-YVAD, caspase 8 inhibitor z-IETD and caspase 10 inhibitor z-AEVD were applied. Among these, z-IETD effectively inhibited oridonin-induced apoptosis in U937 cells, whereas Ac-YVAD and z-AEVD had no effect, suggesting that caspase 8 was likely to be involved (Fig. 3 ). This conclusion gained further support from the morphologic observation that application of caspase 8 inhibitor z-IETD in combination with ordonin decreased the number of apoptotic bodies, in contrast with oridonin alone cases (Fig. 4A) ; and DNA fragmentation analysis revealed that oridonin-induced DNA ladder was significantly attenuated by addition of z-IETD, but addition of Ac-YVAD and z-AEVD only slightly blocked DNA fragmentation (Fig. 4B) .
Up-Regulation of Death-Inducing Signaling Complex (DISC) Protein Expression, Including Fas, FADD and Caspase 8, by Oridonin To further confirm the involvement of Fas/FasL signaling in oridonin-induced apoptosis, the DISC protein expression was examined by Western blot analysis. As shown in Fig. 5 , the expression levels of Fas and FasL significantly and persistently increased after administration of oridonin accompanied by a relative increase in the expression of cytosolic adaptor protein, FADD. In line with the results in Fig. 3 , the result of Western blot analysis also revealed that the protein level of procaspase 8 was reduced rapidly upon 3 h, and then remained at a relatively stable level for the rest of the induction time, indicating that procaspase 8 was cleaved in the early phase to initiate capase cascade, ultimately resulting in apoptosis.
Taken together, these results suggest that Fas/FasL signaling was activated in response to oridonin, which partially or totally accounted for U937 cell apoptosis induced by oridonin.
Oridonin-Induced Cell Death Was Promoted by ERK, but not by PTK and PKC MAPK signaling pathways have been known to play important roles in cell growth and cell death. To evaluate the involvement of MAPK cascade in oridonin-induced cell death, specific inhibitors of ERK (PD98059), p38 (SB203580), JNK (SP600125) were employed. After 12 h incubation with oridonin, 10 mM PD98059 effectively decreased oridonin-induced cell death, while SB203580 and SP600125 failed (Fig. 6 ). There is evidence that protein tyrosine kinase (PTK) and protein kinase C (PKC) regulate ERK activation and participate in Fas/FasL pathway-mediated apoptosis. 17) To assess whether such a mechanism is involved in oridonin-induced U937 cell death, PTK inhibitor genistein was applied to examine the function of PTK in oridonin-treated U937 cell death, and simultaneously, PKC activity assay was carried out. The results showed that treatment with 50 mM genistein in combination with oridonin did not cause the decrease in cell death as observed in the presence of PD98059, on the contrary, genistein increased cell death (data not shown). Also, the failure of oridonin to induce PKC activation (data not shown) indicates neither PTK nor PKC promoted oridonin-induced cell death. that activation of mitogen-activated protein kinase (MAPK) proteins may result from Fas/FasL signaling pathway. 18) Expression of phosphorylated ERK began to increase from 3 h, and then was sustained until 24 h, consistent with our previous study. 14) In contrast, stimulation of U937 with CH11 led to a transient ERK phosphorylation (Fig. 7) . Both oridonin and CH11 had no impact on the ERK protein expression. Since oridonin induced U937 cell apoptosis through Fas/FasL pathway, in combination with evidence that agonistic anti-Fas CH11 induced ERK phosphorylation, these results indicate that ERK activation in response to oridonin might result from Fas/FasL signaling.
ERK Was Activated by Fas/FasL Signaling in Oridonin-Treated Cells
To analyse the role of ERK in Fas/FasL signaling pathway in more detail, we examined the impact of ERK inhibitor PD98059 on the decreased expression of procaspase 8 and increased expression of FADD. Exposure of PD98059 reversed down-regulated procaspase 8 expression observed in the presence of oridonin alone. In contrast, up-regulated FADD expression in response to oridonin was not affected by PD98059 treatment (Fig. 8) . We therefore conclude that ERK can act upstream of caspase 8 to regulate oridonin-induced apoptosis.
Modulation of Bcl-2 Family Proteins, Cytochrome c Release, and Caspase-3 Activation in Oridonin-Induced U937 Cell Apoptosis Accumulating evidence suggests that the mitochondria play a critical role in apoptosis by modulating Bcl-2 family members, such as Bcl-2, Bcl-X L , and Bax, and releasing apoptogenic factors, such as cytochrome c and apoptosis-inducing factor (AIF). 19) After treatment with oridonin for 12 h, the expression of Bcl-2 began to decrease, simultaneously, cytochrome c levels in the cytoplasm increased (Fig. 9 ). Caspase-3 was activated by proteclytic processing of the 32-kDa procaspase into two smaller subunits of 17 and 20 kD, after treatment with 27 mM oridonin for 12 h. These results indicated that oridonin-induced apoptosis was involved in the mitochondria-mediated pathway: the initial phase mediated by Bcl-2 down-regulation, resulting in cytochrome c release from the mitochondria; and the executive phase mediated by the caspase-3 activation.
Contribution of ERK Activation to Cytochrome c Release in Oridonin-Induced Apoptotic U937 Cells To examine whether Bcl-2 downregulation and cytochrome c upregulation in response to oridonin treatment is dependent on ERK activation, MEK inhibitor PD98059 or U0126 are administrated. Treatment with 10 mM PD98059 significantly reversed the increased expression of cytochrome c induced by oridonin and CH11, but had no effect on the downregulation of Bcl-2 protein (Fig. 10) . Similar effects were observed with another ERK inhibitor U0126 treatment. These data suggest activation of ERK by oridonin was required for the release of cytochrome c in the apoptotic U937 cells.
DISCUSSION
Fas/FasL pathway has been implicated as an important cel- The cells (4.0ϫ10 6 ) were treated with oridonin and CH11 for the indicated time periods. Cell lysates were separated by 12% SDS-PAGE, and the protein bands were detected by Western blot analysis. The cells were treated with oridonin for different time periods. The cell lysates were separated by 12% SDS-PAGE, and the protein expression was detected by Western blot analysis. Fig. 10 . Impact of MEK Inhibitors on Oridonin-and CH11-Induced Bcl-2 Downregulation and Cytochrome c Release lular pathway regulating the induction of apoptosis in diverse cell types and tissues. 20) However, some Fas-expressing cancer cells seem to be resistant to apoptotic signaling through this receptor on the basis of a strategy to escape apoptosis mediated by FasL-expessing cytotoxic T cells. 21) For U937 cells tested in this study, engagement of Fas antigen with its agonistic antibody CH11 resulted in apoptosis as monitored by MTT assay and flowcytometric analysis, suggesting U937 cells with the characteristics of Fas sensitivity. This result was in line with the previous report that incubation of U937 cells with an anti-Fas antibody for 4 h induced apoptosis. 17) Our previous studies showed that oridonin inhibited L929 and HeLa cell growth at the doses ranging from 41.2 to 68.7 mM. 11, 22) In contrast, 27 mM oridonin was able to decrease U937 cell growth by 50%, indicating a high sensitivity of U937 cells to oridonin-induced cell death. Caspase 8 has been considered to be the first caspase activated following Fas stimulation with the subsequent assembly of the deathinducing signaling complex (DISC). Our results showed that caspase 8 inhibitor z-IETD reduced oridonin-induced cell death and procaspase 8 expression decreased after treatment with oridonin. This contrasts with our previous study in L929 and HeLa cells lacking caspase 8 activation in the presence of oridonin, indicating that oridonin-induced apoptosis in L929 and HeLa cells is caspase 8 independent. The reason for this discrepancy is not clear, but might be related to the different sensitivity of tumor cells to Fas. In addition, expression of Fas, FasL, and FADD was up-regulated by oridonin treatment. These results suggest that oridonin induced U937 cell death through Fas/FasL signaling.
MAPK members including ERK, JNK, and p38, are reported to play important roles in cell growth and apoptosis. In this study, ERK inhibitor PD98059, but not JNK inhibitor SP600125 and p38 inhibitor SB203580, effectively suppressed oridonin-induced cell death and DNA fragmentation, indicating that ERK MAPK was required for oridonin-induced cell apoptosis. Several previous reports have demonstrated that signal pathways of apoptosis in endothelial cells involve activation of PTK and PKC. 16) A study by Karsan and his colleagues showed that endothelial cell death induced by TNFa was mediated via a PKC pathway. 23) PTK and PKC were thought to transmit signaling events through ERK MAPK. This is in contrast with the present study, in which oridonin fails to induce PKC activation. Moreover, PTK inhibitor genistein did not decrease oridonin-induced cell death, on the contrary, increased cell death. These results suggest that unlike the effect of ERK, PTK and PKC did not contribute to oridonin-induced cell death and ERK was likely to be activated by other signal molecules.
There is evidence that Fas/FasL signaling has the ability to induce JNK and MAPK activation.
7) The present results indeed show that oridonin activated Fas/FasL signaling, in turn, upregulated ERK phosphorylation, as agonistic anti-Fas antibody CH11 did. In addition, PD980589 reversed decreased expression of procaspase 8, but failed to abrogate increased expression of FADD, implying that ERK functions upstream of caspase 8, but FADD independent. Previous studies showed that MAPK was activated in a variety of cell types upon TNFR1 stimulation. This kind of activation also applies for Fas signaling through another adaptor protein, Fas-interacting serine/threonine kinase receptor-interacting protein (RIP). 24) Combination of the previous results with our present observation indicates that ERK activation might be mediated by RIP but not by FADD in response to Fas/FasL signaling. Therefore, further research will be required to elucidate the regulatory mechanisms of ERK activation.
Accumulating evidence shows that apoptosis induction through mitochondrial pathway is related to ERK activation. A study in U937 cells in response to Epigallocatechin-3-gallate (EGCG) plus vanadate indicated that ERK phosphorylation was required for cytochrome c release and caspase-3 activation. 25) Thus, ERK inhibitor PD98059 is used in the present study to investigate the role of ERK activation in changed expression of Bcl-2 protein and cytochrome c release. Pretreatment with PD98059 blocked the increased expression of cytochrome c, but had no influence in down-regulated Bcl-2 protein expression induced by oridonin, suggesting that ERK allows cytochrome c release in the cytoplasm to mediate the mitochondria-dependent apoptotic pathway in response to oridonin. In additon, we have found that Bcl-X L downregulation and Bax upregulation in response to oridonin treatment is dependent on ERK activation, 18) implying that ERK might influence the release of cytochrome c through alteration of ratio of Bcl-X L /Bax, independent of Bcl-2. This is in contrast with the previous study, in which inhibition of ERK activation reversed Bcl-2 downregualtion and cytochrome c release in gemeitabine-induced human nonsmall cell lung cancer H1299 cell apoptosis. 8) In summary, we demonstrated that sensitivity of U937 cells to oridonin-induced apoptosis was associated with Fas/FasL signaling events including increased expression of Fas, FasL, and FADD; and caspase 8 activation. Importantly, this signaling was amplified by ERK pathway, in turn, promoted cytochorome c release from mitochondria, eventually resulting in caspase 3 activation.
